![Mark Watson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Watson
Directeur/Membre du Conseil chez
ABRDN HEALTHCARE OPPORTUNITIES FUND
Profil
Mark Watson is currently the Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. since 2009.
He is also currently serving as an Independent Trustee at abrdn Healthcare Opportunities Fund starting in 2022.
Previously, Mr. Watson held positions as Director at Sykes Enterprises, Inc. from 2018 to 2021, Director at BioDelivery Sciences International, Inc. from 2017 to 2022, and Director at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Postes actifs de Mark Watson
| Sociétés | Poste | Début |
|---|---|---|
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Directeur/Membre du Conseil | 09/06/2022 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Directeur/Membre du Conseil | 01/01/2009 |
Anciens postes connus de Mark Watson
| Sociétés | Poste | Fin |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Directeur/Membre du Conseil | 13/12/2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Membre du Conseil | 02/01/2022 |
| SYKES ENTERPRISES, INCORPORATED | Directeur/Membre du Conseil | 02/01/2021 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sykes Enterprises, Inc.
 Sykes Enterprises, Inc. Information Technology ServicesTechnology Services Provides business process outsourcing services | Technology Services |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
